Dermolab Pharma Ltd. · 66-41 · CANADA

For Dermolab Pharma Ltd. · 66-41 · CANADA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is CANADA; product is Protect Ombracreme | Protect Ombracreme | Protect Ombracreme | Protect Ombracreme | Protect Ombracreme; product code is 53 L - - 01 Cleansing (Cold Creams, Cleansing Lotions, Liquids, Pads) (Skin Care Preparations) | 65 L - - 99 Protectant N.E.C. | 66 P - - 18 Zinc Oxide (Ultraviolet Screen/Sunscreen) | 66 P - - 99 Ultraviolet Screen/Sunscreen N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 11/13/2018; address is 1421 Nobel St , Sainte-Julie, Quebec CANADA, verified against its source on 2026-09-16.

What the source says

Dermolab Pharma Ltd. Date Published : 11/13/2018 1421 Nobel St , Sainte-Julie, Quebec CANADA 53 L - - 01 Cleansing (Cold Creams, Cleansing Lotions, Liquids, Pads) (Skin Care Preparations) Date Published: 11/13/2018 Desc: Protect Ombracreme 65 L - - 99 Protectant N.E.C. Date Published: 11/13/2018 Desc: Protect Ombracreme 66 P - - 18 Zinc Oxide (Ultraviolet Screen/Sunscreen) Date Published: 11/13/2018 Desc: Protect Ombracreme 66 P - - 99 Ultraviolet Screen/Sunscreen N.E.C. Date Published: 11/13/2018 Desc: Protect Ombracreme 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 11/13/2018 Desc: Protect Ombracreme

— accessdata.fda.gov, retrieved 2026-09-15

Source

• accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html

Last verified against source: 2026-09-16. Due for re-check by 2026-11-15. This page as Markdown · OKF bundle · full dataset as JSON.